GLP-1 receptor agonists and pancreatic safety concerns in type 2 diabetic patients: data from cardiovascular outcome trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://link.springer.com/content/pdf/10.1007/s12020-020-02223-6.pdf
Reference35 articles.
1. International Diabetes Federation. IDF diabetes atlas, 9th edn. (2019). http://www.diabetesatlas.org/across-the-globe.html. Accessed 25 Nov 2019
2. R. Pannala, J.B. Leirness, W.R. Bamlet, A. Basu, G.M. Petersen, S.T. Chari, Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134(4), 981–987 (2008). https://doi.org/10.1053/j.gastro.2008.01.039
3. F. Bragg, M.V. Holmes, A. Iona, Y. Guo, H. Du, Y. Chen, Z. Bian, L. Yang, W. Herrington, D. Bennett, I. Turnbull, Y. Liu, S. Feng, J. Chen, R. Clarke, R. Collins, R. Peto, L. Li, G. Z. Chen, China Kadoorie Biobank collaborative: association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA 317(3), 280–289 (2017). https://doi.org/10.1001/jama.2016.19720
4. A. Gonzalez-Perez, R.G. Schlienger, L.A. Rodriguez, Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study. Diabetes Care 33(12), 2580–2585 (2010). https://doi.org/10.2337/dc10-0842
5. C.J. Girman, T.D. Kou, B. Cai, C.M. Alexander, E.A. O’Neill, D.E. Williams-Herman, L. Katz:, Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. Diabetes Obes. Metab. 12(9), 766–771 (2010). https://doi.org/10.1111/j.1463-1326.2010.01231.x
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials;Pharmacological Research;2024-10
2. Non-functional alpha-cell hyperplasia with glucagon-producing NET: a case report;Frontiers in Endocrinology;2024-09-06
3. Incretin‐based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future;Medicinal Research Reviews;2024-08-14
4. Problematic Pharmacokinetics: A Case of Recurrent Pancreatitis Post Discontinuation of a Glucagon-Like Peptide 1 Receptor Agonists;Journal of Pharmacy Practice;2024-08-07
5. A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment;Pharmacological Reports;2024-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3